Related Experiment Video
Updated: Jul 18, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Targeting SARS-CoV-2 Non-Structural Proteins
Donald Tam1, Ana C Lorenzo-Leal1, Luis Ricardo Hernández2
1Division of Infectious Disease, Department of Medicine, University of British Columbia, 2660 Oak Street, Vancouver, BC V6H 3Z6, Canada.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped respiratory β coronavirus that causes coronavirus disease (COVID-19), leading to a deadly pandemic that has claimed millions of lives worldwide. Like other coronaviruses, the SARS-CoV-2 genome also codes for non-structural proteins (NSPs). These NSPs are found within open reading frame 1a (ORF1a) and open reading frame 1ab (ORF1ab) of the SARS-CoV-2 genome and encode NSP1 to NSP11 and NSP12 to NSP16, respectively. This study aimed to collect the available literature regarding NSP inhibitors. In addition, we searched the natural product database looking for similar structures. The results showed that similar structures could be tested as potential inhibitors of the NSPs.
Insights
This study reviews severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structural protein (NSP) inhibitors. Natural product database searches suggest similar structures may inhibit these vital viral proteins.
Area of Science:
- Virology
- Drug Discovery
- Medicinal Chemistry
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global pandemic.
- SARS-CoV-2 encodes non-structural proteins (NSPs) essential for viral replication.
- NSPs are located in open reading frame 1a (ORF1a) and open reading frame 1ab (ORF1ab).
Purpose of the Study:
- To compile existing literature on SARS-CoV-2 NSP inhibitors.
- To identify potential NSP inhibitors from natural product databases.
Main Methods:
- Systematic literature review of NSP inhibitors.
- Natural product database screening for compounds with structural similarity to NSPs.
Main Results:
- A collection of available literature on NSP inhibitors was gathered.
- Structural similarities were identified between natural products and SARS-CoV-2 NSPs.
Conclusions:
- Natural products with structural similarities to SARS-CoV-2 NSPs are potential candidates for inhibitor development.
- Further research is warranted to validate these natural products as effective antiviral agents.
Related Concept Videos
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Leaky Scanning
Structural Protein Function
Subviral Agents
Single Nucleotide Polymorphisms-SNPs
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...

